Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours-Reference-Cited by-同舟云学术

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours

Published:2011-12-06 Issue:12 Volume:6 Page:e28250
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Birch Ashley H.,Arcand Suzanna L.,Oros Kathleen K.,Rahimi Kurosh,Watters A. Kevin,Provencher Diane,Greenwood Celia M.,Mes-Masson Anne-Marie,Tonin Patricia N.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference78 articles.

1. Pathology and classification of ovarian tumors.;VW Chen;Cancer,2003

2. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential.;CL Trimble;Gynecol Oncol,2002

3. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.;MA Crispens;Obstet Gynecol,2002

4. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.;R Vang;Adv Anat Pathol,2009

5. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.;KM Schmeler;Gynecol Oncol,2008

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

2. Molecular Pathogenesis of Lung Cancer: Evolving Landscapes Based on Past Experience;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

3. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients;Modern Pathology;2023-11

4. Routine Clinically Detected Increased ROS1 Transcripts Are Related With ROS1 Expression by Immunohistochemistry and Associated With EGFR Mutations in Lung Adenocarcinoma;JTO Clinical and Research Reports;2023-07

5. Targeting Oncogenic Driver Mutations in Lung Cancer;El in Molecular Onco;2023-01-12